Smith, Moore & Co.
- SEC CIK
- 0000200724
- Latest filing
- Aug 12, 2026
MRTX holding history
Mirati Therapeutics, Inc. in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRTX overviewAll 13F holders of MRTXFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −3,000−100.0% | Sold out | Holders |
| Q3 2022 | 3,000 | $210.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3,000 | $201.0K | <0.1% | +3,000 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −2,000−100.0% | Sold out | Holders |
| Q4 2021 | 2,000 | $293.0K | <0.1% | +500+33.3% | Added | Holders |
| Q3 2021 | 1,500 | $265.0K | <0.1% | +1,500 | New | Holders |